09:13 AM EST, 01/09/2026 (MT Newswires) -- Health care stocks were rising pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF ( XLV ) up 0.2% and the iShares Biotechnology ETF (IBB) advancing by 1.3%.

Insmed ( INSM ) shares were up more than 11% after the company reported preliminary 2025 revenue of $606.4 million, up 67% year over year.

UniQure ( QURE ) shares were nearly 17% higher after the company said it has scheduled a type A meeting with the US Food and Drug Administration to discuss a biologics license application data package for accelerated approval of AMT-130, its investigational gene therapy for the treatment of Huntington's disease.

Aquestive Therapeutics ( AQST ) stock was down more than 37% after the company said the US Food and Drug Administration has identified deficiencies in the company's new drug application for Anaphylm epinephrine sublingual film.